Your browser doesn't support javascript.
loading
A systematic review of validity of US survey measures for assessing substance use and substance use disorders.
Tang, Yuni; Caswell, Erin; Mohamed, Rowida; Wilson, Natalie; Osmanovic, Edis; Smith, Gordon; Hartley, Summer D; Bhandari, Ruchi.
Afiliação
  • Tang Y; Department of Epidemiology and Biostatistics, School of Public Health, West Virginia University, Morgantown, WV, 26501, USA.
  • Caswell E; Highway Safety Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Mohamed R; Department of Epidemiology and Biostatistics, School of Public Health, West Virginia University, Morgantown, WV, 26501, USA.
  • Wilson N; Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Morgantown, WV, USA.
  • Osmanovic E; Biological Sciences Division, University of Chicago, Chicago, USA, IL.
  • Smith G; Health Affairs Institute, West Virginia University, Morgantown, WV, USA.
  • Hartley SD; Health Affairs Institute, West Virginia University, Morgantown, WV, USA.
  • Bhandari R; Department of Epidemiology and Biostatistics, School of Public Health, West Virginia University, Morgantown, WV, 26501, USA.
Syst Rev ; 13(1): 166, 2024 Jun 27.
Article em En | MEDLINE | ID: mdl-38937847
ABSTRACT

BACKGROUND:

The steep rise in substance use and substance use disorder (SUD) shows an urgency to assess its prevalence using valid measures. This systematic review summarizes the validity of measures to assess the prevalence of substance use and SUD in the US estimated in population and sub-population-based surveys.

METHODS:

A literature search was performed using nine online databases. Studies were included in the review if they were published in English and tested the validity of substance use and SUD measures among US adults at the general or sub-population level. Independent reviews were conducted by the authors to complete data synthesis and assess the risk of bias.

RESULTS:

Overall, 46 studies validating substance use/SUD (n = 46) measures were included in this review, in which 63% were conducted in clinical settings and 89% assessed the validity of SUD measures. Among the studies that assessed SUD screening measures, 78% examined a generic SUD measure, and the rest screened for specific disorders. Almost every study used a different survey measure. Overall, sensitivity and specificity tests were conducted in over a third of the studies for validation, and 10 studies used receiver operating characteristics curve.

CONCLUSION:

Findings suggest a lack of standardized methods in surveys measuring and reporting prevalence of substance use/SUD among US adults. It highlights a critical need to develop short measures for assessing SUD that do not require lengthy, time-consuming data collection that would be difficult to incorporate into population-based surveys assessing a multitude of health dimensions. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42022298280.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Syst Rev Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Syst Rev Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos